Thomas McEachin - 12 May 2022 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Director
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 17:07:14 UTC
Previous filing
17 Aug 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +8,480 +50% $0.000000 25,321 12 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2023.